ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION
Abbott today announced it has received CE Mark for its fourth-generation MitraClip™ Transcatheter Mitral Valve Repair System, the leading minimally invasive mitral valve repair device in the world.
NEW RESEARCH FINDS PHYSICIANS AND PATIENTS POINT TO EMERGING TECHNOLOGY AND DATA AS CENTRAL TO CLOSING TREATMENT GAPS AND IMPROVING VASCULAR HEALTH
New global research, released today from Abbott, takes a deep dive into the barriers of cardiovascular patient care and shows that more than 80% of physicians and hospital administrators view technology and data as critical to addressing challenges before, during and after treatment.
ABBOTT ANNOUNCES START OF TRIAL TO EVALUATE THE NEW ESPRIT™ BTK DRUG-ELUTING RESORBABLE SCAFFOLD
This is the first Investigational Device Exemption (IDE) trial in the U.S. to evaluate a fully resorbable device to treat blocked arteries below the knees, or critical limb ischemia (CLI), in people battling advanced stages of peripheral artery disease (PAD).
Download Abbott Labs (adc) Port Devices Drivers
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Welcome to i-stat system support. Click DOWNLOAD to print, email or download the full Product Catalog as a PDF. To do the same for a specific product or page, click the PRINT, EMAIL or PDF button on the page itself. This 5 feet EZSync cable is plug-and-paly and simply will work under Windows 10, 8 and 7 immediately without driver installation. It does NOT work with Mac. This cable is not designed or manufactured by Abbott laboratories. Work with AlphaTRAKer software to download, manage and report data. Compatible with Alphatrack 2 glucose diabetes meter.
IMPORTANT: Work with your healthcare professional to understand your reports. LibreView provides a standard set of information and graphs relating to your diabetes management and is only one part of understanding your glucose patterns.
Use the report labels and legends to understand your reports. Additional Information is provided below:
Download Abbott Labs (adc) Port Devices Driver Windows 10
Glucose Management Indicator (GMI) uses average Sensor glucose data. GMI can provide an indication of the current state of a your glucose management when used in conjunction with your entire glucose management program. Your laboratory A1C may be different then your GMI, and should be discussed with your health care team.
In reports other than those with specific fixed standards, the glucose values are labeled as high when higher than 250 mg/dL (13.9 mmol/L) and low when lower than 70 mg/dL (3.9 mmol/L) by default. The default target range is set for 70-180 mg/dL (3.9-8.0 mmol/L). These ranges can be adjusted for certain reports, other than the standard reports, which have specifically selected target ranges.
The target glucose range is displayed on some glucose graphs and is used to calculate Time in Target and Time in Range, except where standard ranges are applied.
Sensor data captured is the percentage of possible Sensor data the device recorded from scanning your Sensor. To maximize this percentage, wear your Sensor for the entire timeframe and scan as per Sensor instructions.
Sometimes information may be missing from reports if:
You did not wear the Sensor for the entire timeframe.
You did not scan at least once every 8 hours.
You did not enter food and/or insulin information in your device.
You changed the time on the device.
There was an excess of information to include in the report.
